The short version
What teams need to understand
- Regulatory changes must be implemented through defined and controlled actions.
- Each action must have a clear owner, timeline, and expected outcome.
- Implementation must include updates to SOPs, systems, training, and processes where required.
- Actions must be tracked from initiation through to completion.
- Completion must be verified to ensure regulatory compliance is achieved.
- Inspection-ready evidence must demonstrate that regulatory changes are implemented effectively and not left incomplete.
Regulatory expectation
What regulators expect
Each expectation should be supported by controlled documentation, traceable records, clear ownership, and evidence that the process works in practice.
- Regulatory changes must be implemented.
- Actions must be defined and assigned.
- Implementation must be tracked.
- Completion must be verified.
- The PV system must reflect updated regulatory requirements.
Why it matters
What this means in practice
Inspectors assess whether pharmacovigilance systems implement regulatory changes effectively. They review action tracking, ownership, deadlines, and evidence that required changes are completed and have achieved compliance across the PV system.
Questions this page answers
Inspection evidence
Evidence teams should be able to show
Regulatory Intelligence Action Tracker
- Central tracking of regulatory actions
- Assignment of owners for each action
- Defined timelines and deadlines
- Status updates from identification to completion
Action Implementation Records
- SOP updates reflecting regulatory changes
- System configuration updates
- Documentation of implemented process changes
- Evidence of completed actions
Ownership and Responsibility Records
- Defined responsibility for each action
- Cross-functional ownership (PV, QA, RA, IT, etc.)
- Accountability for implementation outcomes
- Escalation of delayed actions
Timeline and Deadline Tracking
- Defined regulatory compliance deadlines
- Internal target dates for implementation
- Monitoring of progress against deadlines
- Identification of overdue actions
Completion Verification and Evidence
- Confirmation that actions are completed
- Evidence linking implementation to regulatory requirement
- QA verification of completed changes
- Closure records for regulatory intelligence items
Regulatory Basis (Primary Sources)
- GVP Module I - requirement to maintain compliance through effective quality systems
- GVP Module VI - requirement to align PV processes with regulatory obligations
- ICH E2E - requirement to plan and implement PV system changes proactively
- MHRA GPvP guidance - expectation for implementation of regulatory requirements
- FDA pharmacovigilance guidance - requirement to ensure compliance through action and execution
Typical Inspection Questions (What Inspectors Ask)
- How do you implement regulatory changes?
- Show me the actions taken for this regulatory update.
- How do you track implementation progress?
- How do you ensure actions are completed on time?
- How do you confirm compliance has been achieved?
Common failure patterns
What good looks like
- Clear and structured action plans for regulatory changes.
- Defined ownership and accountability for each action.
- Active tracking of implementation progress.
- Timely completion of actions aligned with regulatory deadlines.
- Verified implementation ensuring compliance is achieved.
How teams operationalise it
- Define actions following regulatory impact assessment.
- Assign owners and deadlines for each action.
- Track actions through a central regulatory intelligence tracker.
- Monitor progress regularly and escalate delays.
- Verify completion of actions and confirm compliance.
- Document implementation evidence for audit and inspection.
From expectation to working control
Find the documentation that supports this work
Review the related toolkit to understand its purpose, included files, and how it supports this regulatory expectation.
Frequently asked questions
How are regulatory changes implemented in pharmacovigilance?
Regulatory changes are implemented through defined actions such as updating SOPs, modifying systems, delivering training, and aligning processes to meet new requirements.
What is action tracking in regulatory intelligence?
Action tracking is the process of monitoring regulatory actions from assignment through to completion, ensuring accountability and timely execution.
How do companies ensure regulatory compliance after changes?
Companies ensure compliance by implementing defined actions, tracking progress, verifying completion, and confirming that processes align with regulatory requirements.
Do inspectors review implementation of regulatory changes?
Yes. Inspectors review whether regulatory changes are implemented, tracked, and completed effectively.
What evidence is required for regulatory implementation?
Evidence includes updated SOPs, system changes, training records, action tracking logs, and verification of completed actions.
What happens if regulatory actions are not completed?
Incomplete actions can result in non-compliance and inspection findings, particularly if regulatory deadlines are missed.
Source boundary
Regulatory sources
These primary sources inform this structured interpretation. Always confirm current requirements against the original source and the requirements applicable to your organisation, product, and jurisdiction.
European Medicines Agency (EMA)
Guideline on good pharmacovigilance practices (GVP) - Module I
View sourceGuideline on good pharmacovigilance practices (GVP) - Module VI
View source
FDA
FDA Postmarketing Safety Reporting
View source
ICH
ICH E2E Pharmacovigilance Planning
View source
MHRA
Good Pharmacovigilance Practice (GPvP)
View source